Paradise Regained: Achieving Remission in Depression

Identifies pharmacological, herbal, and integrative approaches useful in remission-oriented management of unipolar depression/major depressive disorder and bipolar disorder. Outlines the issues of neurotransmitter-affecting medications, associated side effects, and interactions with other medications, including drugs used in dental practice. Discusses the optimal strategies for treatment augmentation in cases of treatment-resistant depression. Discusses experimental treatments for depression (e.g., transcranial magnetic therapy and vagus nerve stimulation) with patients.

Be the first to review this product

Format:

Booklet

$30.00

Qty:

Hour 1

Introduction
Drugs for UD/MDD
Treatment Variations for Cases of UD/MDD

Hour 2

What Can Be Done for Treatment-Resistant UD/MDD
Psychotherapy
Herbal Remedies
Ginseng

Hour 3

Valerian Root
Omega-3 Fatty Acids
Experimental Approaches
Vagus Nerve Stimulation (VNS)
Addendum

Learning Objectives

Identify pharmacological, herbal, and integrative approaches useful in remission-oriented management of unipolar depression/major depressive disorder and bipolar disorder.
Outline the issues of neurotransmitter-affecting medications, associated side effects, and interactions with other medications, including drugs used in dental practice.
Discuss the optimal strategies for treatment augmentation in cases of treatment-resistant depression.
Discuss experimental treatments for depression (e.g., transcranial magnetic therapy and vagus nerve stimulation) with patients.

Products specifications

Instructor	N. Katz, M.D., Ph.D.
More Information About This Course:	Paradise Regained: Achieving Remission in Depression accreditation
# of Pages	57
Contact Hours:	3
NCBTMB Contact Hours	3 (Not Approved for NY)

Customers who bought this item also bought

Anti-Anxiety Drugs

Outlines the diagnostic issues of various anxiety disorders including GAD, panic disorder, OCD, and social phobia. Identifies differentials of anxiety disorders and the nomenclature of phobias and related conditions. Describes commonly used pharmacological agents and their interactions, side effects, and expected effects. Addresses the issue of co-administration of these drugs with dental drugs. Identifies approaches to co-management of anxiety and depression, anxiety and alcohol-related disorders, and acute toxicity of benzodiazepines.

$30.00

Cognitive Behavior Therapy

Identifies the major components of cognitive behavioral therapy and the causative relationship between environmental events, thoughts, emotions, and behavior. Lists the common types of flawed and irrational beliefs that create depression, anxiety, and stress. Describes the “ABC” process of converting irrational thinking into rational thinking. Describes cognitive-behavioral treatment strategies for depression and anxiety. Defines “allostasis” and “allostatic load” aspects of stress and describe the “Stress Inoculation Training” approach to stress management.

$30.00

Memory Loss & Forgetfulness

Identifies the memory changes that take place in normal aging. Discusses how mild cognitive impairment (MCI) differs from memory loss in normal aging and from dementia. Describes the cognitive and personality changes that take place in Alzheimer’s disease. Identifies cognitive and personality changes that occur in a range of non-Alzheimer’s disease dementias.

$30.00